Cargando…
Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime(®)) and the recombinant Leish-110f(®) + MPL-SE(®) vaccine to treat canine visceral leishmaniasis
The evaluation of the efficacy of an immunochemotherapy protocol to treat symptomatic dogs naturally infected with Leishmania chagasi was studied. This clinical trial had the purpose to test the combination of N-methyl meglumine antimoniate (Glucantime(®)) and the second generation recombinant vacci...
Autores principales: | Miret, Jorge, Nascimento, Evaldo, Sampaio, Weverton, França, João Carlos, Fujiwara, Ricardo Toshio, Vale, André, Dias, Edelberto Santos, Vieira, Edvá, Costa, Roberto Teodoro da, Mayrink, Wilson, Neto, Antonio Campos, Reed, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127155/ https://www.ncbi.nlm.nih.gov/pubmed/18328956 http://dx.doi.org/10.1016/j.vaccine.2008.01.026 |
Ejemplares similares
-
Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
por: Layegh, Pouran, et al.
Publicado: (2011) -
Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime(®)) in Cutaneous Leishmaniasis
por: Albalawi, Aishah E., et al.
Publicado: (2021) -
First Report on Infant Acute Urticaria after Mother’s Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report
por: MOZAFARI, Omid, et al.
Publicado: (2016) -
Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
por: Sorkhroodi, F Zamani, et al.
Publicado: (2010) -
FIRST REPORT ON OTOTOXICITY OF MEGLUMINE
ANTIMONIATE
por: Valete-Rosalino, Cláudia Maria, et al.
Publicado: (2014)